MetLife Investment Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-59,442
| Closed | -$1.4M | – | 2836 |
|
|
2023
Q4 | $1.4M | Buy |
59,442
+7,640
| +15% | +$180K | 0.01% | 1130 |
|
|
2023
Q3 | $772K | Hold |
51,802
| – | – | 0.01% | 1373 |
|
|
2023
Q2 | $567K | Buy |
+51,802
| New | +$567K | ﹤0.01% | 1614 |
|
|
2022
Q2 | – | Sell |
-52,338
| Closed | -$163K | – | 2923 |
|
|
2022
Q1 | $163K | Buy |
+52,338
| New | +$163K | ﹤0.01% | 2475 |
|
|
2021
Q4 | – | Sell |
-26,489
| Closed | -$96.7K | – | 2568 |
|
|
2021
Q3 | $96.7K | Buy |
+26,489
| New | +$96.7K | ﹤0.01% | 2455 |
|
|
2021
Q2 | – | Sell |
-31,252
| Closed | -$142K | – | 2504 |
|
|
2021
Q1 | $142K | Buy |
31,252
+15,959
| +104% | +$72.5K | ﹤0.01% | 2206 |
|
|
2020
Q4 | $87.8K | Sell |
15,293
-6,111
| -29% | -$35.1K | ﹤0.01% | 2236 |
|
|
2020
Q3 | $155K | Sell |
21,404
-13,457
| -39% | -$97.4K | ﹤0.01% | 2010 |
|
|
2020
Q2 | $122K | Buy |
+34,861
| New | +$122K | ﹤0.01% | 2161 |
|
|
2019
Q4 | – | Sell |
-24,969
| Closed | -$128K | – | 2340 |
|
|
2019
Q3 | $128K | Sell |
24,969
-16,881
| -40% | -$86.4K | ﹤0.01% | 2199 |
|
|
2019
Q2 | $300K | Buy |
41,850
+13,672
| +49% | +$97.9K | ﹤0.01% | 1785 |
|
|
2019
Q1 | $374K | Hold |
28,178
| – | – | ﹤0.01% | 1626 |
|
|
2018
Q4 | $222K | Hold |
28,178
| – | – | ﹤0.01% | 1852 |
|
|
2018
Q3 | $312K | Hold |
28,178
| – | – | ﹤0.01% | 1833 |
|
|
2018
Q2 | $378K | Buy |
+28,178
| New | +$378K | ﹤0.01% | 1585 |
|